Ranking by Regions
United States
Canada
Mexico
Brazil
Chile
Germany
United Kingdom
France
Spain
Netherlands
Sweden
Italy
Switzerland
Poland
Finland
China
Japan
South Korea
Hong Kong
Singapore
Indonesia
India
Malaysia
Taiwan
Thailand
Australia
New Zealand
Israel
Saudi Arabia
Turkey
Russia
South AfricaRanking by categories
As of January 22, 2025, Morphic Therapeutic (MORF) has a market cap of $2.86 billion USD. According to our data, Morphic Therapeutic is ranked No.3554 in global market value.
| Year | Market Cap | %Change |
|---|---|---|
| Aug 15, 2024 | $2.86 B |
97.32%
|
| Dec 29, 2023 | $1.45 B |
7.96%
|
| Dec 30, 2022 | $1.34 B |
-43.54%
|
| Dec 31, 2021 | $2.38 B |
41.22%
|
| Dec 31, 2020 | $1.69 B |
95.51%
|
| Dec 31, 2019 | $0.86 B |
100%
|
| Name | Market Cap | Market cap difference | Regions |
|---|---|---|---|
 AbbVie
ABBV
|
$300.53 B |
0.002 M
|
USA
|
 Gilead Sciences
GILD
|
$116.07 B |
0.004 M
|
USA
|
 Bristol-Myers Squibb
BMY
|
$115.86 B |
0.003 M
|
USA
|
 Amgen
AMGN
|
$147.53 B |
0.002 M
|
USA
|
 Biogen
BIIB
|
$20.80 B |
-0.001 M
|
USA
|
 Regeneron Pharmaceuticals
REGN
|
$75.23 B |
1.245 B
|
USA
|
 Incyte
INCY
|
$14.05 B |
-0.000 M
|
USA
|
 Alkermes
ALKS
|
$4.90 B |
0.000 M
|
Ireland
|
 Ironwood Pharmaceuticals
IRWD
|
$0.60 B |
0.000 M
|
USA
|
 Sarepta Therapeutics
SRPT
|
$11.08 B |
-0.000 M
|
USA
|
 Blueprint Medicines
BPMC
|
$7.10 B |
-0.000 M
|
USA
|
| Market Cap | = | MORF Stock Price | * | MORF Shares Outstanding |
| = | $56.99 | * | 50.22 M | |
| = | $2.86 B |